Publication | Closed Access

A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients

Rheumatoid DisorderRheumatologyHidden ” ImmunogenicityAutoimmune DiseaseMedicineRheumatic DiseasesImmunologyAntibody ScreeningAutoimmunityAutoantibodiesAntibody EngineeringRheumatoid Arthritis PatientsDrug RevealsImmunochemistryInflammatory Rheumatic DiseaseImmunotherapyPharmacologyRheumatoid Arthritis